Related Experiment Video

Updated: Jun 24, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

Myocardial protection against reperfusion injury: the cGMP pathway

David Garcia-Dorado1, Luis Agulló, Carmem Lluisa Sartorio

  • 1Laboratorio de Cardiología Experimental, Area del Cor, Hospital Universitari Vall d'Hebron, Barcelona, Spain. dgdorado@vhebron.net

Thrombosis and Haemostasis
|April 8, 2009
PubMed

Insights

Reperfusion injury after acute myocardial infarction causes cell death. The cyclic guanosine monophosphate (cGMP) pathway is crucial for protecting heart cells and offers a potential therapeutic target.

Area of Science:

  • Cardiovascular Science
  • Cellular Biology
  • Biochemistry

Background:

  • Reperfusion injury contributes to myocardial cell death, limiting treatment benefits in acute myocardial infarction.
  • Key mechanisms involve calcium handling, hypercontraction, cytoskeletal damage, mitochondrial dysfunction, and cell-to-cell death propagation.
  • Alterations in non-cardiomyocyte cells like platelets and endothelial cells also play a role.

Purpose of the Study:

  • To investigate the role of cyclic guanosine monophosphate (cGMP) in myocardial ischemia-reperfusion injury.
  • To explore the cGMP pathway as a potential therapeutic target for acute myocardial infarction.

Main Methods:

  • Review of existing literature on myocardial reperfusion injury and cGMP signaling.
  • Analysis of mechanisms involving calcium handling, cellular integrity, and cell death propagation.
  • Examination of the role of cGMP and its synthesis in cardiomyocytes and endothelial cells.

Main Results:

  • cGMP favorably modulates key mechanisms of reperfusion injury, primarily via protein kinase G (PKG).
  • cGMP synthesis is altered in reperfused cells through incompletely understood pathways.
  • Natriuretic peptides stimulate cGMP synthesis, demonstrating protective effects in animal models and patients.

Conclusions:

  • The cGMP pathway is integral to the pathophysiology of myocardial ischemia-reperfusion.
  • cGMP signaling is a critical component of endogenous cardioprotection.
  • Targeting the cGMP pathway presents a promising therapeutic strategy for acute myocardial infarction patients.

More Related Videos

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...